Agile Therapeutics
AGRX
$0.38
Share price
-5.47%
Change (1 day)
-91.40%
Change (1 year)
Categories
Agile Therapeutics (AGRX) - Total assets
Total assets on the balance sheet as of December 2023 : $10.25 M
According to Agile Therapeutics 's latest financial reports the company's total assets are $10.25 M. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Agile Therapeutics - Total assets on balance sheet (from 2013 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $14.24 M | -63.79% |
| 2021-12-31 | $39.33 M | -46.16% |
| 2020-12-31 | $73.06 M | 47.48% |
| 2019-12-31 | $49.54 M | 121.24% |
| 2018-12-31 | $22.39 M | -55.74% |
| 2017-12-31 | $50.59 M | -20.78% |
| 2016-12-31 | $63.86 M | 26.67% |
| 2015-12-31 | $50.42 M | -8.03% |
| 2014-12-31 | $54.82 M | 280.6% |
| 2013-12-31 | $14.4 M | -47.65% |
| 2012-12-31 | $27.51 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $171.96 B | 1,676,799.07% | 🇺🇸 USA |
 Pfizer PFE | $226.50 B | 2,208,588.44% | 🇺🇸 USA |
 Merck MRK | $106.67 B | 1,040,124.28% | 🇺🇸 USA |
 TherapeuticsMD TXMD | $50.49 M | 392.37% | 🇺🇸 USA |
 Antares Pharma ATRS | N/A | N/A | 🇺🇸 USA |